Actual Medicinal Product (AMP) Edurant 25mg tablets (Janssen-Cilag Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Manufacturer recommends storing in original container.
No stability data in MCAs available. - Provenance
-
This recommendation is based on the product Edurant 25mg tablets (Janssen-Cilag Ltd).
- Generic
- Rilpivirine
- Formulation
- Rilpivirine 25mg tablets
-
Rilpivirine
-
Rilpivirine 25mg tablets
-
Edurant 25mg tablets (Janssen-Cilag Ltd)
-
-